321 related articles for article (PubMed ID: 27694174)
21. A preliminary study of anti-1-amino-3-18F-fluorocyclobutyl-1-carboxylic acid for the detection of prostate cancer.
Oka S; Hattori R; Kurosaki F; Toyama M; Williams LA; Yu W; Votaw JR; Yoshida Y; Goodman MM; Ito O
J Nucl Med; 2007 Jan; 48(1):46-55. PubMed ID: 17204698
[TBL] [Abstract][Full Text] [Related]
22. Regional distribution and kinetics of [18F]fluciclovine (anti-[18F]FACBC), a tracer of amino acid transport, in subjects with primary prostate cancer.
Sörensen J; Owenius R; Lax M; Johansson S
Eur J Nucl Med Mol Imaging; 2013 Feb; 40(3):394-402. PubMed ID: 23208700
[TBL] [Abstract][Full Text] [Related]
23. Positron emission tomography (PET) radiotracers for prostate cancer imaging.
Walker SM; Lim I; Lindenberg L; Mena E; Choyke PL; Turkbey B
Abdom Radiol (NY); 2020 Jul; 45(7):2165-2175. PubMed ID: 32047993
[TBL] [Abstract][Full Text] [Related]
24. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer.
Zhang X; Cai W; Cao F; Schreibmann E; Wu Y; Wu JC; Xing L; Chen X
J Nucl Med; 2006 Mar; 47(3):492-501. PubMed ID: 16513619
[TBL] [Abstract][Full Text] [Related]
25. Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of Breast Cancer: An Exploratory Study.
Tade FI; Cohen MA; Styblo TM; Odewole OA; Holbrook AI; Newell MS; Savir-Baruch B; Li X; Goodman MM; Nye JA; Schuster DM
J Nucl Med; 2016 Sep; 57(9):1357-63. PubMed ID: 27056619
[TBL] [Abstract][Full Text] [Related]
26. Molecular Imaging of Prostate Cancer.
Wibmer AG; Burger IA; Sala E; Hricak H; Weber WA; Vargas HA
Radiographics; 2016; 36(1):142-59. PubMed ID: 26587888
[TBL] [Abstract][Full Text] [Related]
27. PET Tracer
Oka S; Kanagawa M; Doi Y; Schuster DM; Goodman MM; Yoshimura H
Theranostics; 2017; 7(7):2048-2064. PubMed ID: 28656060
[No Abstract] [Full Text] [Related]
28. Combined
Elschot M; Selnæs KM; Sandsmark E; Krüger-Stokke B; Størkersen Ø; Giskeødegård GF; Tessem MB; Moestue SA; Bertilsson H; Bathen TF
J Nucl Med; 2018 May; 59(5):762-768. PubMed ID: 28986510
[TBL] [Abstract][Full Text] [Related]
29. A review discussing fluciclovine (
Zanoni L; Bossert I; Matti A; Schiavina R; Pultrone C; Fanti S; Nanni C
Future Oncol; 2018 May; 14(11):1101-1115. PubMed ID: 29359581
[TBL] [Abstract][Full Text] [Related]
30. Pilot evaluation of anti-1-amino-2-[18F] fluorocyclopentane-1-carboxylic acid (anti-2-[18F] FACPC) PET-CT in recurrent prostate carcinoma.
Savir-Baruch B; Schuster DM; Jarkas N; Master VA; Nieh PT; Halkar RK; Nye JA; Lewis MM; Crowe RJ; Voll RJ; Camp VM; Bellamy LM; Roberts DL; Goodman MM
Mol Imaging Biol; 2011 Dec; 13(6):1272-7. PubMed ID: 20976627
[TBL] [Abstract][Full Text] [Related]
31. Extraprostatic Uptake of
Robertson MS; Sakellis CG; Hyun H; Jacene HA
AJR Am J Roentgenol; 2020 Mar; 214(3):641-648. PubMed ID: 31939697
[No Abstract] [Full Text] [Related]
32. 18F-FACBC compared with 11C-choline PET/CT in patients with biochemical relapse after radical prostatectomy: a prospective study in 28 patients.
Nanni C; Schiavina R; Brunocilla E; Borghesi M; Ambrosini V; Zanoni L; Gentile G; Vagnoni V; Romagnoli D; Martorana G; Fanti S
Clin Genitourin Cancer; 2014 Apr; 12(2):106-10. PubMed ID: 24135632
[TBL] [Abstract][Full Text] [Related]
33. Bombesin-Targeted PET of Prostate Cancer.
Mansi R; Minamimoto R; Mäcke H; Iagaru AH
J Nucl Med; 2016 Oct; 57(Suppl 3):67S-72S. PubMed ID: 27694175
[TBL] [Abstract][Full Text] [Related]
34. Assessment of Amino Acid/Drug Transporters for Renal Transport of [
Ono M; Baden A; Okudaira H; Kobayashi M; Kawai K; Oka S; Yoshimura H
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754421
[TBL] [Abstract][Full Text] [Related]
35. Multifocal Meningiomas Mimicking Dural-Based Intracranial Metastases at 18F-Fluciclovine PET/CT.
Manganaro MS; Millet JD; Manganaro MS
Clin Nucl Med; 2019 Jul; 44(7):594-595. PubMed ID: 31107759
[TBL] [Abstract][Full Text] [Related]
36. Metastatic Male Breast Cancer With Increased Uptake on 18F-Fluciclovine PET/CT Scan.
Gill HS; Tade F; Greenwald DT; Yonover PM; Savir-Baruch B
Clin Nucl Med; 2018 Jan; 43(1):23-24. PubMed ID: 29189374
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.
DeGrado TR; Coleman RE; Wang S; Baldwin SW; Orr MD; Robertson CN; Polascik TJ; Price DT
Cancer Res; 2001 Jan; 61(1):110-7. PubMed ID: 11196147
[TBL] [Abstract][Full Text] [Related]
38. PET of Glucose Metabolism and Cellular Proliferation in Prostate Cancer.
Jadvar H
J Nucl Med; 2016 Oct; 57(Suppl 3):25S-29S. PubMed ID: 27694167
[TBL] [Abstract][Full Text] [Related]
39. The value of anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT in the diagnosis of recurrent prostate carcinoma: a meta-analysis.
Ren J; Yuan L; Wen G; Yang J
Acta Radiol; 2016 Apr; 57(4):487-93. PubMed ID: 25907118
[TBL] [Abstract][Full Text] [Related]
40. 18F-labeled bombesin analog for specific and effective targeting of prostate tumors expressing gastrin-releasing peptide receptors.
Honer M; Mu L; Stellfeld T; Graham K; Martic M; Fischer CR; Lehmann L; Schubiger PA; Ametamey SM; Dinkelborg L; Srinivasan A; Borkowski S
J Nucl Med; 2011 Feb; 52(2):270-8. PubMed ID: 21233180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
